Mark Hoenerhoff, DVM, PhD, DACVP

Mark Hoenerhoff

Role

IVAC Pathology
ULAM Faculty

Job Title

Clinical Associate Professor, Unit for Laboratory Animal Medicine (ULAM)

Additional Titles

Pathologist, In-Vivo Animal Core (IVAC)

Profile

Dr. Hoenerhoff is a board-certified veterinary pathologist with a strong background in translational research, including cancer biology and comparative pathology. Dr. Hoenerhoff has extensive research experience through the National Cancer Institute, National Institutes of Health, where he studied mouse models of breast cancer and stem cell theory of carcinogenesis. He was also a member of the National Toxicology Program, where he was involved in interpretation of toxicology and carcinogenicity bioassays and large scale global gene expression analysis of rodent neoplasia and its relevance to human cancer. Dr. Hoenerhoff joined the ULAM faculty in February of 2014, and is a member of the In-Vivo Animal Core (IVAC) Pathology team within ULAM.

 

RESEARCH INTERESTS

Dr. Hoenerhoff's primary research interests include pathology of animal models of human disease, xenograft and genetically engineered mouse models, and toxicologic and diagnostic pathology. 

Professional Background

  • BS (Veterinary Science), Michigan State University
  • DVM, Michigan State University
  • Diplomate, American College of Veterinary Pathology
  • PhD, Michigan State University and National Cancer Institute, National Institutes of Health
     
  1. El Touny LH, Vieira A, Mendoza A, Khanna C, Hoenerhoff MJ, Green JE. Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells.  J Clin Invest. 2014 (Epub ahead of print).
     
  2. Chappell G, Kutanzi K, Uehara T, Tryndyak V, Hong HH, Hoenerhoff MJ, Beland FA, Rusyn I, Pogribny IP. Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice. Int J Cancer. 2013 (Epub ahead of print).
     
  3. Blackshear PE, Pandiri AR, Ton TV, Clayton NP, Shockley KR, Peddada SD, Gerrish KE, Sills RC, Hoenerhoff, MJ. Spontaneous Mesotheliomas in F344/N Rats are Characterized by Dysregulation of Cellular Growth and Immune Function Pathways. Toxicol Pathol. 2013 (Epub ahead of print).
     
  4. Elmore SA, Hoenerhoff MJ, Katsuta O, Kokoshima H, Maronpot R, Nagai H, Satoh H, Tanaka Y, Tochitani T, Tsuchiya S, Yoshizawa K. Proceedings of the 2013 Joint JSTP/NTP Satellite Symposium. J Toxicol Pathol. 2013, 26(2):231-57.
     
  5. Bhusari S, Malarkey DE, Hong HH, Wang Y, Masinde T, Nolan M, Hooth MJ, Lea IA, Vasconcelos D, Sills RC, Hoenerhoff MJ. Mutation Spectra of Kras and Tp53 in Urethral and Lung Neoplasms in B6C3F1 Mice Treated with 3,3`,4,4`-Tetrachloroazobenzene. Toxicol Pathol. 2014;42(3):555-64
     
  6. National Toxicology Program. Toxicology and carcinogenesis studies of pyrogallol (CAS No. 87-66-1) in F344/N rats and B6C3F1/N mice (dermal studies)Natl Toxicol Program Tech Rep Ser. 2013, 574:1-167.
     
  7. National Toxicology Program. Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (Gavage studies)Natl Toxicol Program Tech Rep Ser. 2013, 578:1-183.
     
  8. Hoenerhoff MJ, Pandiri AR, Snyder SA, Hong HH, Ton T-V, Peddada S, Shockley KR, Witt K, Chan P, Rider C, Kooistra L, Nyska A, Sills RC. Hepatocellular carcinomas in B6C3F1 mice treated with Ginkgo biloba extract for two-years differ from spontaneous liver tumors in cancer gene mutations and genomic pathways. Toxicol Pathol, 2012, 39(4): 678-99.
     
  9. Elmore SA, Berridge BR, Boyle MC, Cora MC, Hoenerhoff MJ, Kooistra L, Laast VA, Morrison JP, Rao D, Rinke M, Yoshizawa K. Proceedings of the 2012 National Toxicology Program Satellite Symposium. Toxicol Pathol, 2013, 41:325-342.
     
  10. National Toxicology Program. Toxicology and carcinogenesis study of styrene-acrylonitrile trimer in F344/N rats (perinatal and postnatal feed studies). Natl Toxicol Program Tech Rep Ser, Dec 21 2012.
     
  11. Pandiri AR, Sills RC, Ziglioli V, Ton TV, Hong HH, Lahousse SA, Gerrish K, Auerbach SS, Shockley KR, Bushel PR, Peddada SD, Hoenerhoff MJ. Differential Transcriptomic Analysis of Spontaneous Lung Tumors in B6C3F1 Mice: Comparison to Human Non-Small Cell Lung Cancer. Toxicol Pathol. 2012, 40(8):1141-1159.
     
  12. Ray RM, Myers PH, Painter JT, Hoenerhoff MJ, Olden K, Roberts JD. Inhibition of Transforming Growth Factor-b-activated Kinase-1 Blocks Cancer Cell Adhesion, Invasion, and Metastasis. Br J Cancer. 2012, 107(1):129-36.
     
  13. Hudson TS, Carlson BA, Hoenerhoff MJ, Young HA, Sordillo L, Muller WJ, Hatfield DL, Green JE. Selenoproteins reduce susceptibility to DMBA-induced mammary carcinogenesis. Carcinogenesis 2012, 33(6):1225-30.
     
  14. Koivisto C, Flake GP, Kolenda-Roberts H, Masinde T, Kissling GE, Sills RC, Hoenerhoff MJ. Immunohistochemical Investigation of F344/N Rat Islet Cell Tumors from National Toxicology Program Studies. Toxicol Pathol 2012, 40(5):751-63.
     
  15. Chu IM, Michalowksi AM, Hoenerhoff MJ, Szauter M, Luger D, Sato M, Oshima A, Csiszar K, Green JE. GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells. Oncogene 2012, 31(16):2017-2027.
     
  16. Pandiri, AR, Sills RC, Hoenerhoff MJ, Peddada SD, Ton TV, Hong HH, Flake GP, Malarkey DE, Olsen GR, Pogriby IP, Walker NJ, Boudreau MD. Aloe vera Non-Decolorized Whole Leaf Extract-Induced Large Intestinal Tumors in F344 Rats Share Similar Molecular Pathways with Human Sporadic Colorectal Tumors. Toxicol Pathol 2011, 39(7):1065-74.
     
  17. Hoenerhoff MJ, Chu IM, Green JE. BMI1 suffers a degrading experience. Cell Cycle 2011. 15;10(12):1894-5.
     
  18. Hoenerhoff MJ, Pandiri AP, Lahousse SA, Ton TV, Hong HL, Shockley K, Bushel PR, Peddada S, Sills RC. Global Gene Profiling of Spontaneous Hepatocellular Carcinoma in B6C3F1 Mice: Similarities in the Molecular Landscape with Human Liver Cancer. J Tox Pathol 2011, 39(4):678-99.
     
  19. Wei BR, Martin PL, Hoover SB, Spehalski E, Kumar M, Hoenerhoff MJ, Rozenberg J, Vinson C, Simpson RM. Capacity for Resolution of RAS-MAPK Initiated Early Pathogenic Myocardial Hypertrophy Modeled in Mice. Comp Med 2011, 61(2):109-18.
     
  20. Cannon CZ, Kissling GE, Hoenerhoff MJ, King-Herbert AP, Blankenship-Paris T. Evaluation of dosages and routes of administration of tramadol analgesia in rats using hot-plate and tail-flick tests. Lab Anim 2010, 39(11):342-51.
     
  21. Hoenerhoff MJ, Shibata M-A, Bode A, Green JE. Pathologic Progression of Mammary Carcinomas in a C3(1)/SV40 T/t-antigen Transgenic Rat Model of Human Triple-negative and Her2-positive Breast Cancer. Trans Res 2010, 20(2):247-59.
     
  22. Lahousse SA, Hoenerhoff MJ, Collins J, Ton T-V, Masinde T, Olson D, Rebolloso Y, Koujitani T, Tomer KB, Hong HA, Bucher J, Sills RC. Gene expression and mutation assessment provide clues of genetic and epigenetic mechanisms of oxazepam-induced liver tumors in mice. Vet Pathol 48(4):875-84.
     
  23. Ghosh S, Hoenerhoff MJ, Clayton N, Myers P, Stumpo DJ, Maronpot RR, Blackshear PJ. Left-sided cardiac valvulitis in tristetraprolin-deficient mice: The role of tumor necrosis factor a. Amer J Pathol 2010, 176(3):1484-93.
     
  24. Hoenerhoff MJ, Hong HH, Ton T-V, Lahousse SA, Sills RC. A review of the molecular mechanisms of chemically-induced neoplasia in rat and mouse models in National Toxicology Program bioassays and their relevance to human cancer. Toxicol Pathol 2009, 37(7):835-48.
     
  25. Hoenerhoff MJ, Chu I, Barkan D, Datta S, Dimri GP, Green JE. BMI1 cooperates with H-RAS to induce and aggressive breast cancer phenotype with brain metastases. Oncogene. 2009, Aug 27;28(34):3022-32.
     
  26. Barkan D, Kleinman H, Simmons JL, Asmussen H, Kamaraju AK, Hoenerhoff MJ, Liu ZY, Costes SV, Cho EH, Lockett S, Khanna C, Chambers AF, Green JE. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res 2008, Aug 1; 68(15):6241-50.
     
  27. Datta S, Hoenerhoff MJ, Bommi P, Sainger R, Guo W, Dimri M, Band H, Band V, Green JE, Dimri GP. BMI1 cooperates with H-RAS to transform human mammary epithelial cells via dysregulation of multiple growth regulatory pathways. Cancer Res 2007, Nov 1; 67(21):10286-10295.
     
  28. Deeb KK, Michalowska AM, Yoon CY, Krummey SM, Hoenerhoff MJ, Kavanaugh C, Li MC, Demayo FJ, Linnoila I, Deng CX, Lee EY, Medina D, Shih JH, Green JE. Identification of an Integrated SV40 T/t-Antigen Cancer Signature in Aggressive Human Breast, Prostate, and Lung Carcinomas with Poor Prognosis. Cancer Res 2007, Sep 1; 67(17):8065-8080.
     
  29. Hoenerhoff MJ, Starost MF, Ward JE. High incidence of eosinophilic crystalline pneumonia in 129S4/SvJae mice. Vet Pathol 2006, 43: 682-688.
     
  30. Blackshear PE, Pandiri AR, Nagai H, Bhusari S, Hong HH, Ton TV, Clayton NP, Wyde M, Shockley KR, Peddada SD, Gerrish KE, Sills RC, Hoenerhoff MJ. Gene Expression of Mesothelioma in Vinylidene Chloride-Exposed F344/N Rats Reveals Immune Dysfunction, Tissue Damage, and Inflammation Pathways. Toxicol Pathol. 2015, 43(2):171-85.
     
  31. Laast VA, Larsen T, Allison N, Hoenerhoff MJ, Boorman GA. Distinguishing Cystic Degeneration from Other Aging Lesions in the Adrenal Cortex of Sprague-Dawley Rats. Toxicol Pathol, 2014, 42(5):823-29.
     
  32. Quist EM, Filgo AJ, Cummings CA, Kissling GE, Hoenerhoff MJ, Fenton SE. Hepatic mitochondrial alteration in CD1 mice associated with prenatal exposures to low doses of perfluorooctanoic acid (PFOA). Toxicol Pathol. 2015, 43(4):546-557.
     
  33. Hoenerhoff MJ, Hartke J. A Brief Overview of the “Epigenetic Endpoints in Toxicologic Pathology and Relevance to Human Health” Session of the 2014 Society of Toxicologic Pathology Annual Symposium. Toxicol Pathol. 2015, 43(1):41-7.
     
  34. Hoenerhoff MJ, Silverman L, Francke S. A Brief Overview of the 33rd Annual Symposium on Translational Pathology: Relevance of Toxicologic Pathology to Human Health. Toxicol Pathol. 2015, 43(1):98-100.
     
  35. Filgo AJ, Quist EM, Hoenerhoff MJ, Brix AE, Kissling GE, Fenton SE. Perfluorooctanoic Acid (PFOA)-induced Live Lesions in Two Strains of Mice Following Developmental Exposures: PPARa Is Not Required. Toxicol Pathol. 2015, 43(4):558-68.
     
  36. Harvey JB, Hong HH, Bhusari S, Ton T-V, Wang Y, Foley JF, Peddada SD, Hooth M, DeVito M, Nyska A, Pandiri AR, Hoenerhoff MJ. F344/NTac Rats Chronically Exposed to Bromodichloroacetic Acid Develop Mammary Adenocarcinomas With Mixed Luminal/Basal Phenotype and Tgfb Dysregulation. Vet Pathol. (Epub ahead of print).
     
  37. Hong HH, Hoenerhoff MJ, Ton T-V, Herbert RA, Kissling GE, Hooth MJ, Behl M, Witt KL, Smith-Roe SL, Sills RC, Pandiri AR. Kras, Egfr, and Tp53 mutations in B6C3F1/N Mouse and F344/NTac Rat Alveolar/Bronchiolar Carcinomas Resulting from Chronic Inhalation Exposure to Cobalt Metal. Toxicol Pathol. 2015, 43(6):872-82.
     
  38. Cronin S, Lin A, Thompson K, Hoeneroff MJ, Duncan RK. Hearing Loss and Otopathology Following Systemic and Intracerebroventricular Delivery of 2-Hydroxypropyl-Beta-Cyclodextrin. J Assoc Res Otolaryngol. 2015, 16(5): 599-611.
     
  39. Harvey JB, Osborne TS, Hong HH, Bhusari S, Ton T-V, Pandiri AR, Masinde T, Dunnick J, Peddada SD, Elmore SA, Hoenerhoff MJ. Uterine Carcinomas in Tetrabromobisphenol A-Exposed Wistar Han Rats Harbor Increased Tp53 Mutations and Mimic High-Grade Type I Endometrial Carcinomas in Women. Toxicol Pathol. 2015 (Epub ahead of print).
     
  40. Invited Editorial: Hoenerhoff MJ. Inflammation and cancer: Partners in crime. Vet J. 2015, 206(1):1-2.
     
  41. Kommareddi P, Nair T, Galano MM, Miller D, Laczkovich I, Kakaraparthi BN, Kabara L, Rule K, Kanicki A, Saunders TL, Hughes ED, Jones JM, Thomas T, Altschuler RA, Hoenerhoff MJ, Dolan D, Kohrman D, Carey TE. Hair Cell Loss, Spiral Ganglion Degeneration, and Progressive Sensorineural Hearing Loss in Mice with Targeted Deletion of Ctl2/Slc44a2. J Assoc Res Orolaryngol. 2015 (Epub ahead of print).